Chapter 1 Understanding Digital Therapeutics
   1.1 Definition
   1.2 Key Features
   1.3 Development Timeline
   1.4 Applications
   1.5 Global Digital Therapeutics Market

Chapter 2 Korean Digital Therapeutics Market
   2.1 Breakthrough Device Designation
   2.2 Product Approval of MFDS
   2.3 National Health Insurance Listing
   2.3.1 Breakthrough Technology Designation
   2.4 Clinical Trial Approvals of MFDS
   2.5 Current R&D in Korea

Chapter 3 Major Suppliers of DTx in Korea
   3.1 NUNAPS
   3.2 DoBrain
   3.3 LifeSemantics
   3.4 S-Alpha Therapeutics
   3.5 AIMMED
   3.6 WELT
   3.7 Other Suppliers
      3.7.1 Neudive
      3.7.2 Medimind
      3.7.3 Emocog
      3.7.4 HAII
      3.7.5 Huraypositive

Chapter 4 Business Issues and Forecasts of Digital Therapeutics Market in Korea
   4.1 Digital Therapeutics Spectrum Classified as Medical Devices
   4.2 Scope of Reimbursement DTx
   4.3 Market Access Model of DTx in Korea
      4.3.1 Target Conditions and Intended Uses
      4.3.2 Clinical Grounds
      4.3.3 National Health Insurance Listing Forecast
      4.3.4 Business Model Forecast

References

Appendix 1 Clinical Trials on Digital Therapeutics

[Table 1] Types and Examples of Personal Healthcare Products
[Table 2] Examples of Digital Therapeutics and Intended Uses
[Table 3] DTx Development Process
[Table 4] DTx Applications
[Table 5] Global DTx Suppliers
[Table 6] Breakthrough DTx Designation
[Table 7] DTx Approvals
[Table 8] DTx Approval Forecasts
[Table 9] New Health Technology Notifications - Cognitive Behavioral Therapy for Chronic Insomnia Patients
[Table 10] Breakthrough Technology Notification - Chronic Insomnia Improvement Using Cognitive Behavioral Therapy Software
[Table 11] Breakthrough Technology Criteria
[Table 12] Potetial Value of Breakthrough Technology Criteria
[Table 13] Clinical Trial Approvals on DTx Products 2021-2023
[Table 14] Clinical Trial Approvals on DTx Products in Korea 2021-2023
[Table 15] DTx R&D in Korea
[Table 16] Major Suppliers of Digital Therapeutics
[Table 17] Major Products Development and Launch
[Table 18] S-Alpha Therapeutics Products
[Table 19] Information on Approvals for Somzz by AIMMED
[Table 20] New Health Technology Notifications - Cognitive Behavioral Therapy for Chronic Insomnia Patients
[Table 21] Information on Approvals for Pillow RX by WELT
[Table 22] WELT DTx Development
[Table 23] National Health Insurance Listing of DTx - Breakthrough Technology

[Fig 1] Digital Therapeutics Spectrum
[Fig 2] Eligibility Flowchart of Digital Therapeutics
[Fig 3] Key Features of Digital Therapeutics
[Fig 4] Global Market Size and Forecast 2022-2025 (in 10,000 USD)
[Fig 5] Flowchart of Digital Therapeutics Alliance
[Fig 6] Korean Market Size and Forecast 2022-2025 (in 10,000 USD)
[Fig 7] Integrated Review Process of Breakthrough Device Designation
[Fig 8] Digital Therapeutics IDE Approvals 2021-2023
[Fig 9] Five-Year (2023-2027) Comprehensive Plan for Development & Support of the Medical Devices Industry
[Fig 10] Product Image of VIVID Brain
[Fig 11] Educational Mobile App Screen of DoBrain Inc.
[Fig 12] Screen Capture of Redpill Breath by LifeSemantics
[Fig 13] Functions of Redpill Breath
[Fig 14] Screen Capture of Somzz by AIMMED
[Fig 15] Screen Capture of NUROW Games by AIMMED
[Fig 16] Screen Capture of Pillow RX of WELT Corp.
[Fig 17] Forecast of National Health Insurance Listing Process for Digital Therapeutics
[Fig 18] Breakthrough Technology Assessment Process
[Fig 19] Forecast of Digital Therapeutics Reimbursement System
[Fig 20] Forecast of Prescription Digital Therapeutics Reimbursement Scheme
[Fig 21] Forecast of Prescription Digital Therapeutics Reimbursement Methods

1 NUNAPS
2 DoBrain
3 LifeSemantics
4 S-Alpha Therapeutics
5 AIMMED
6 WELT
7 Neudive
8 Medimind
9 Emocog
10 HAII
11 Huraypositive
12 NeuroEars
13 Neopons
14 DIGITAL PHARM
15 MINDsAI
17 Tech Village